HEADING FOR A CURE
There are certain ailments that we simply live with because a cure seems so out of reach; instead we soothe the symptoms and try not to let them get us down. One of the biggest – and most debilitating – has to be migraines. They affect more than 23 per cent of adults, causing almost 200,000 attacks every day, but they have no cure. Until now, that is. The first drug specifically designed to prevent migraine, Erenumab, has been approved by European health officials. English and Scottish health agencies will now decide whether it’s appropriate for NHS use but, whatever the decision, patients should be able to get it privately from September if they have at least four migraines a month. It works by blocking a peptide receptor, thought to activate migraines. So if you’re a sufferer, or look out for someone who is, this is cause for celebration.
Leggete l'articolo completo e molti altri in questo numero di
Healthy Magazine
Opzioni di acquisto di seguito
Se il problema è vostro,
Accesso
per leggere subito l'articolo completo.
Singolo numero digitale
OctNov 18
Questo numero speciale non è incluso in un nuovo
Healthy Magazine
abbonamento. Gli abbonamenti comprendono l'ultimo numero regolare e i nuovi numeri pubblicati durante l'abbonamento.